Published in Int Tinnitus J on January 01, 2001
A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis (1986) 2.24
Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J Immunol (1985) 2.24
Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med (1966) 2.12
Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. J Infect Dis (1992) 1.90
Laboratory infection with Zika virus after vaccination against yellow fever. Arch Gesamte Virusforsch (1973) 1.83
Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin. Antimicrob Agents Chemother (1981) 1.61
Renal dysfunction in Brazilian lead workers. Am J Nephrol (1987) 1.58
Comparison of bile and trypticase soy broth for isolation Salmonella from blood. Am J Clin Pathol (1966) 1.52
Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet (1986) 1.42
Circulating immune complexes and rheumatoid factor in schistosomiasis and visceral leishmaniasis. Am J Trop Med Hyg (1983) 1.38
Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis. Am J Trop Med Hyg (1995) 1.26
Problems in salmonellosis: rationale for clinical trials with newer beta-lactam agents and quinolones. Rev Infect Dis (1986) 1.14
Etiology and mortality of bacterial meningitis in northeastern Brazil. Rev Infect Dis (1990) 1.13
Nephrotic syndrome in patients with Schistosoma mansoni infection. Am J Trop Med Hyg (1973) 1.13
Renal involvement in visceral leishmaniasis. Am J Kidney Dis (1985) 1.10
Serum creatine phosphokinase in leptospirosis. JAMA (1975) 1.10
Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. J Immunol (1991) 1.09
Evaluation of cefamandole therapy of patients with bacterial meningitis. J Infect Dis (1978) 1.03
Bacterial infections in patients with visceral leishmaniasis. J Infect Dis (1990) 1.03
In vitro antibiotic susceptibility of salmonellae. Antimicrob Agents Chemother (1977) 1.01
About the "Pathological" role of the mtDNA T3308C mutationellipsis. Am J Hum Genet (1999) 1.00
Comparison of parenteral ampicillin and parenteral chloramphenicol in the treatment of typhoid fever. Ann N Y Acad Sci (1967) 0.98
Hyperargininemia presenting as persistent neonatal jaundice and hepatic cirrhosis. J Pediatr Gastroenterol Nutr (1997) 0.98
Schistosoma mansoni-induced mesangiocapillary glomerulonephritis: influence of therapy. Kidney Int (1989) 0.97
[Racial differences between patients with focal segmental glomerulosclerosis and membranoproliferative glomerulonephritis from the State of Bahia]. Rev Assoc Med Bras (1999) 0.97
Distribution and genetic diversity of tomato-infecting begomoviruses in Brazil. Arch Virol (2003) 0.97
Prolonged Salmonella bacteremia in patients with Schistosoma mansoni infection. Arch Intern Med (1971) 0.96
Cefamandole treatment of Salmonella bacteremia. Antimicrob Agents Chemother (1982) 0.96
Urinary concentrating ability in early experimental pyelonephritis. J Clin Invest (1970) 0.95
Schistosomal glomerulopathy. Kidney Int (1979) 0.94
Clonally related penicillin-nonsusceptible Streptococcus pneumoniae serotype 14 from cases of meningitis in Salvador, Brazil. Clin Infect Dis (2000) 0.93
Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis. Antimicrob Agents Chemother (1985) 0.92
Visceral leishmaniasis: a disease associated with inability of lymphocytes to activate macrophages to kill leishmania. Braz J Med Biol Res (1988) 0.92
Effect of bile on the action of blood against Salmonella. J Bacteriol (1966) 0.91
[Myo-relaxant action of sodium Dantrolene in the treatment of tetanus]. Rev Inst Med Trop Sao Paulo (1976) 0.91
Experimental pyelonephritis: characteristics of infection in rats following reduction of bladder capacity. Proc Soc Exp Biol Med (1965) 0.88
Moxalactam for the treatment of bacterial meningitis in children. J Infect Dis (1983) 0.87
Experimental pyelonephritis in rats with a glass bead in the bladder. J Pathol Bacteriol (1965) 0.85
Renal involvement in patients with hepatosplenic Schistosomiasis mansoni. Am J Trop Med Hyg (1976) 0.84
Immunological features in different clinical forms of strongyloidiasis. Trans R Soc Trop Med Hyg (1983) 0.84
The ND1 T3308C mutation may be a mtDNA polymorphism. Report of two Portuguese patients. J Inherit Metab Dis (1999) 0.83
Tetanus as a cause of acute renal failure: possible role of rhabdomyolysis. Rev Soc Bras Med Trop (1994) 0.83
Mucosal leishmaniasis: quantitative nasal cytology as a marker of disease activity and indicator of healing. Ann Otol Rhinol Laryngol (2000) 0.83
[Characteristics of Salmonella typhi infection in mice with experimental schistosomiasis: multiplication of the bacteria in Schistosoma mansoni]. Rev Inst Med Trop Sao Paulo (1972) 0.83
Primary focal segmental glomerulosclerosis in children: prognostic factors. Pediatr Nephrol (2001) 0.82
Evaluation of T-cell subsets in the lesion infiltrates of human cutaneous and mucocutaneous leishmaniasis. Parasite Immunol (1987) 0.82
[Association between race and incidence of end-stage renal disease secondary to glomerulonephritis: influence of the histologic type and presence of arterial hypertension]. Rev Assoc Med Bras (2001) 0.81
Comparison of the complement fixation test and counterelectrophoresis test for the detection of antibodies in Chagas disease. J Clin Microbiol (1976) 0.81
[Clinical study of mixed infections of the urinary tract]. Hospital (Rio J) (1965) 0.80
[Increase in the frequency of norfloxacin and ciprofloxacin resistance of bacteria isolated from urine culture]. Rev Assoc Med Bras (1999) 0.79
[Characteristics of the inflammatory reaction in patients with hepatosplenic forms of schistosomiasis mansoni and kala-azar]. Rev Inst Med Trop Sao Paulo (1969) 0.79
Acoustic neurinomas. Diagnosis and treatment. Arq Neuropsiquiatr (1997) 0.79
Caroli's disease with congenital hepatic fibrosis and medullary sponge kidney. J Pediatr Gastroenterol Nutr (1994) 0.79
[Is glomerulopathy due to schistosomiasis mansoni disappearing?]. Rev Soc Bras Med Trop (1997) 0.78
The burden of pneumonia among children. J Trop Pediatr (2001) 0.78
Clinical course of focal segmental glomerulosclerosis associated with hepatosplenic schistosomiasis mansoni. Nephron (1995) 0.78
Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi. Braz J Med Biol Res (1994) 0.78
Relapse of urinary tract infection in the presence of urinary tract calculi: the role of bacteria within the calculi. J Med Microbiol (1969) 0.78
Race and glomerulonephritis in patients with and without hepatosplenic Schistosomiasis mansoni. Clin Nephrol (2002) 0.77
Is rhabdomyolysis an additional factor in the pathogenesis of acute renal failure in leptospirosis? Rev Inst Med Trop Sao Paulo (1995) 0.77
Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis. Am J Med (1984) 0.77
Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: study of 19 heterozygous and 2 homozygous patients. Hum Mutat (1997) 0.77
Value of beta 1C/1A globulin serum levels as an early index of glomerular involvement in Schistosoma mansoni infection. Am J Trop Med Hyg (1980) 0.77
Renal involvement in prolonged Salmonella bacteremia: the role of schistosomal glomerulopathy. Rev Inst Med Trop Sao Paulo (1994) 0.77
Absence of clinical abnormalities suggesting renal involvement during the long-term course of visceral leishmaniasis. Rev Soc Bras Med Trop (1989) 0.77
Immune complexes in schistosomiasis. VI--Circulating IC levels in patients with and without nephropathy. Rev Inst Med Trop Sao Paulo (1980) 0.76
Clinical effects of intermittent, intravenous cyclophosphamide in severe systemic lupus erythematosus. Nephron (1996) 0.76
The influence of anti-parasitic therapy on the course of the glomerulopathy associated with Schistosomiasis mansoni. Clin Nephrol (1987) 0.75
[Establishment of S. typhimurium infection in mice with schistosomiasis mansoni]. Rev Inst Med Trop Sao Paulo (1973) 0.75
Site of action of nitrofurantoin in experimental urinary tract infection. Appl Microbiol (1969) 0.75
Community acquired pneumonia among pediatric outpatients in Salvador, Northeast Brazil, with emphasis on the role of pneumococcus. Braz J Infect Dis (2001) 0.75
["Transfer factor" in ophthalmology (author's transl)]. Klin Monbl Augenheilkd (1977) 0.75
The role of glutathione in renal cortical tissue. Effects of diamide on Na+ and GSSG levels, amino acid transport and Na+-K+-ATPase activity. Mol Cell Biochem (1977) 0.75
Schistosomal glomerulonephritis: is it more prevalent in hepatosplenic patients when cor pulmonale is present? Rev Soc Bras Med Trop (1990) 0.75
[Bacterial infection in patients with visceral leishmaniasis]. Mem Inst Oswaldo Cruz (1986) 0.75
[Causes of error in the diagnosis of pyelonephritis in a general hospital in our area]. AMB Rev Assoc Med Bras (1973) 0.75
The effect of acute uremia on liver mitochondrial activity. Nephron (1976) 0.75
[Treatment of glomerulopathy in schistosomiasis mansoni. Effect of corticosteroids, cyclophosphamide and schistosomicides]. Rev Inst Med Trop Sao Paulo (1979) 0.75
[Correlations between the basic and the professional cycles]. AMB Rev Assoc Med Bras (1971) 0.75
Effect of acute experimental uremia on the stability of liver lysosomal membranes. Nephron (1977) 0.75
Tobramycin in chronic recurrent urinary tract infections. Am J Med Sci (1976) 0.75
[Oculocutaneous polydysplasic syndrome]. Bull Mem Soc Fr Ophtalmol (1976) 0.75
[Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study]. Rev Bras Pesqui Med Biol (1975) 0.75
[Corticotherapy, the eye, and T and B lymphocytes]. Bull Mem Soc Fr Ophtalmol (1976) 0.75
[Single daily dose of amikacin in the treatment of urinary tract infections]. AMB Rev Assoc Med Bras (1980) 0.75
[Some aspects of cryo-ophthalmology]. Buch Augenarzt (1974) 0.75
[Pattern of renal diseases in autopsied patients in a general hospital of our area]. AMB Rev Assoc Med Bras (1974) 0.75
Indanyl carbenicillin in the treatment of chronic urinary tract infection. Rev Bras Pesqui Med Biol (1975) 0.75
[Bacterial flora of urinary tract infections: changes in sensitivity to antibiotics over a 5 year period]. AMB Rev Assoc Med Bras (1972) 0.75
[Efficacy of moxalactam in the treatment of purulent meningitis caused by Haemophilus influenzae and Neisseria meningitidis]. Mem Inst Oswaldo Cruz (1984) 0.75
[Urinary infection by bacteria of the Salmonella genus]. Rev Inst Med Trop Sao Paulo (1974) 0.75
The reversible inhibition of gluconeogenesis in kidney cortex by diazenedicarboxylic acid bis (N,N-dimethylamide). Eur J Biochem (1977) 0.75
Dynamics of connective matrix deposition in acute experimental E. coli pyelonephritis in rats. Exp Toxicol Pathol (1994) 0.75
[The association of severe clinical forms of strongyloidiasis and intestinal amoebiasis]. Rev Inst Med Trop Sao Paulo (1976) 0.75
[Treatment of bacterial meningitis with cefamandole]. Rev Inst Med Trop Sao Paulo (1979) 0.75
Comparison of bacterial counts in the urine obtained by midstream method, suprapubic needle aspiration and catheterization of the bladder in women with uterovaginal prolapse and vaginal discharge. Rev Bras Pesqui Med Biol (1974) 0.75
Policies, laws, and regulations pertaining to antibiotics: report of Task Force 3. Rev Infect Dis (1987) 0.75
Spectral changes of nucleic acids and nucleotide solutions at the 190-220nm region. An Acad Bras Cienc (1976) 0.75
[Urinary tract infections]. AMB Rev Assoc Med Bras (1988) 0.75
Pharmacokinetics of cefoperazone in normal subjects and patients with hepatosplenic schistosomiasis. J Antimicrob Chemother (1983) 0.75